Outcomes at baseline and postintervention
| n = 22 . | Baseline . | Postintervention . | Change in mean from pre to post (SD) . | P value . |
|---|---|---|---|---|
| Short Physical Performance Battery, mean (SD)* | 9.0 (1.7) | 9.2 (2.4) | +0.2 (1.6) | .61 |
| Brief Fatigue Inventory, mean (SD)† | 29.4 (20.8) | 23.2 (18.8) | −6.2 (17.9) | .12 |
| Center for Epidemiologic Studies Depression, mean (SD)† | 11.7 (7.7) | 10.6 (7.5) | −0.6 (6.1) | .65 |
| Functional Assessment of Cancer Therapy-Leukemia, mean (SD)* | 123.9 (24.7) | 127.1 (22.9) | +3.2 (18.1) | .42 |
| n = 22 . | Baseline . | Postintervention . | Change in mean from pre to post (SD) . | P value . |
|---|---|---|---|---|
| Short Physical Performance Battery, mean (SD)* | 9.0 (1.7) | 9.2 (2.4) | +0.2 (1.6) | .61 |
| Brief Fatigue Inventory, mean (SD)† | 29.4 (20.8) | 23.2 (18.8) | −6.2 (17.9) | .12 |
| Center for Epidemiologic Studies Depression, mean (SD)† | 11.7 (7.7) | 10.6 (7.5) | −0.6 (6.1) | .65 |
| Functional Assessment of Cancer Therapy-Leukemia, mean (SD)* | 123.9 (24.7) | 127.1 (22.9) | +3.2 (18.1) | .42 |